Stocks
Imunon, Inc.IMNN
NASDAQHealthcareBiotechnology$1.24
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing nucleic acid-based therapies and vaccines, with a focus on oncology and infectious diseases. Its lead candidates include a personalized DNA immunotherapy for ovarian cancer and a COVID-19 vaccine candidate. Investors track the company for its proprietary delivery platform and upcoming clinical data readouts.
52W Range: $0.96-$4.93
Congressional Interest in Imunon, Inc. (IMNN)
No congressional trades have been disclosed for Imunon, Inc. (IMNN) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading IMNN?
No congressional trades found for this stock.